Inflammatory Bowel Disease Linked to Prostate Cancer
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Browsing: Clinical Breakthroughs
World’s Smallest Wearable Device Warns of UV Exposure, Enables Precision Phototherapy
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
High Blood Pressure Before Age 40 Linked to Heart Disease
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
Fighting Cancer, Becoming an Adult
Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
An Exceptional Cancer Center
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
Genetic Variants in Caffeine Perception
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
Skin Sensor Could Improve Life for a Million Hydrocephalus Patients
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.
Minimally Invasive Surgery Leads to Worse Survival for Cervical Cancer Patients
Minimally invasive hysterectomy results in worse overall survival outcomes for cancer patients than traditional open surgery, according to a new study.
Steadying the Symptoms of Parkinson’s Disease
Northwestern Medicine clinicians are at the forefront in using an advanced surgical treatment called deep brain stimulation to improve quality of life for patients with Parkinson’s and other movement disorders.
Investigating Treatment for High-Risk Breast Cancer
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.